Sunshine Heart Announces Company Name Change to CHF Solutions, Inc. and New NASDAQ Ticker Symbol to Reflect New Commercial Fo...
May 23 2017 - 7:00AM
Sunshine Heart, Inc. (NASDAQ:SSH), an early-stage medical
device company focused on the commercialization of the Aquadex
FlexFlow® System, today announced that on May 23, 2017, it is
changing the name of the company to CHF Solutions, Inc.
“We are pleased to align our corporate name and identity with
our new commercial focus,” said John Erb, Chairman of the Board and
CEO of CHF Solutions. “CHF Solutions has great brand recognition in
the marketplace and more appropriately reflects our business
direction.”
In conjunction with the name change, the company’s ticker symbol
listed on the NASDAQ will change from SSH to CHFS, which is
expected to be effective May 24,2017, and the CUSIP numbers for its
common stock, Series E Convertible Preferred Stock and the warrants
issued in the Company’s underwritten public offering that closed on
April 24, 2017 will change to 12542Q 102, 12542Q 201 and 12542Q
128, respectively. The company's official website will be changed
to www.chf-solutions.com, effective immediately.
About CHF SolutionsCHF
Solutions, Inc. (Nasdaq:CHFS) is an early-stage medical device
company focused on commercializing the Aquadex FlexFlow® System.
The company's commercial product, the Aquadex system, is indicated
for temporary (up to eight hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy, and
extended (longer than 8 hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy and
require hospitalization. The company’s objective is to improve the
quality of life for patients with heart failure and related
conditions. CHF Solutions is a Delaware corporation
headquartered in Minneapolis with wholly owned
subsidiaries in Australia and Ireland. The company
has been listed on the NASDAQ Capital Market since February
2012.
Forward-Looking StatementsCertain statements in
this release are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, including
statements regarding the company’s ticker symbol and events or
developments that we expect or anticipate will occur in the
future. Forward-looking statements are predictions,
projections and other statements about future events that are based
on current expectations and assumptions and, as a result, are
subject to risks and uncertainties. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this release, including, without limitation, those
risk associated with our ability to execute on our recently
announced strategic realignment, the possibility that we may be
unable to raise sufficient funds necessary for our anticipated
operations, our post-market clinical data collection activities,
benefits of our products to patients, our expectations with respect
to product development and commercialization efforts, our ability
to increase market and physician acceptance of our products,
potentially competitive product offerings, intellectual property
protection, our ability to integrate acquired businesses, our
expectations regarding anticipated synergies with and benefits from
acquired businesses, and other risks and uncertainties described in
our filings with the SEC. Forward-looking statements speak only as
of the date when made. CHF Solutions does not assume any obligation
to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
For further information, please contact:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
T: +1-952-345-4205
Investor Relations
CHF Solutions, Inc.
ir@chf-solutions.com
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Aug 2024 to Sep 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Sep 2023 to Sep 2024